THYROID EYE DISEASE

This study is testing whether satralizumab, an injectable medication, can help control moderate-to-severe thyroid eye disease. About 131 participants will receive either the drug or a placebo to see if it reduces eye bulging, double vision, pain, and improves quality of life. The…

This study is testing whether VRDN-003 injections are safe and how the body processes the drug in people with thyroid eye disease. Participants receive injections every 4 or 8 weeks and researchers monitor for side effects. The trial includes 87 adults with thyroid eye disease wh…

This study is testing whether regular injections of an experimental drug called VRDN-003 can help people with active Thyroid Eye Disease. About 117 participants will receive either the drug or a placebo injection every 4 or 8 weeks to see if it reduces eye bulging, inflammation, …

This study follows up with patients who received an experimental drug called Lu AG22515 for moderate-to-severe Thyroid Eye Disease. The main goal is to see if the treatment continues to reduce eye bulging over time. Researchers are tracking 20 adults to monitor the drug's long-te…

This study continues research on batoclimab for thyroid eye disease in people who finished earlier trials. It has two parts: one observes how long eye improvements last without treatment, while the other gives batoclimab to measure its effectiveness. The study involves 180 partic…

This study is testing whether weekly injections of an experimental drug called batoclimab can reduce eye bulging and inflammation in people with active Thyroid Eye Disease. About 100 participants will receive either the drug or a placebo for 24 weeks to see which is better at pul…

This Phase 3 trial is testing whether an injectable medication called teprotumumab can reduce eye bulging and other symptoms in people with active, moderate-to-severe Thyroid Eye Disease. The study involves 89 participants who receive either the drug or a placebo injection to com…

This Phase 3 study is testing whether an injectable medication called satralizumab can help people with moderate-to-severe thyroid eye disease. The trial will measure if the treatment reduces eye bulging, eases pain and double vision, and improves quality of life. It involves 127…

This study is testing whether regular injections of an investigational drug called VRDN-003 can help control chronic Thyroid Eye Disease. About 195 participants with moderate to severe symptoms will receive either the drug or a placebo injection every 4 or 8 weeks. Researchers wi…